BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10912130)

  • 1. [Prevention of ischemic complications. ACE inhibitor helps in endothelial crisis].
    MMW Fortschr Med; 1999 Oct; 141(43):58-9. PubMed ID: 10912130
    [No Abstract]   [Full Text] [Related]  

  • 2. [Better endothelial function, fewer ischemic problems. An ACE inhibitor provides protection against ischemia].
    MMW Fortschr Med; 2000 Jan; 142(1-2):54-5. PubMed ID: 11291163
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hypertensive patients with signs of coronary heart disease. An ACE inhibitor improves endothelial function].
    MMW Fortschr Med; 2001 Aug; 143(33-34):58-9. PubMed ID: 11561465
    [No Abstract]   [Full Text] [Related]  

  • 4. [Decreasing blood pressure and more: ACE inhibitor in coronary heart disease?].
    MMW Fortschr Med; 2000 Oct; 142(42):50-1. PubMed ID: 11077829
    [No Abstract]   [Full Text] [Related]  

  • 5. Angiotensin-converting enzyme inhibitors in patients with atherosclerosis and preserved left ventricular function: clinical outcomes.
    Pepine C
    Can J Cardiol; 1998 Jul; 14 Suppl D():23D-26D. PubMed ID: 9713427
    [No Abstract]   [Full Text] [Related]  

  • 6. BANFF: an update.
    Anderson T
    Can J Cardiol; 1999 Apr; 15 Suppl B():29B-30B. PubMed ID: 10350682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale for ACE inhibition as an anti-ischaemic therapy.
    Pepine CJ
    Eur Heart J; 1998 Jul; 19 Suppl G():G34-40. PubMed ID: 9717054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Endothelium research. ACE inhibitor with high vascular affinity].
    Riem L
    MMW Fortschr Med; 2000 Jun; 142(22):56-7. PubMed ID: 10870387
    [No Abstract]   [Full Text] [Related]  

  • 9. Quinapril for coronary artery disease.
    Seth S; Mohan A
    Natl Med J India; 1997; 10(2):73-4. PubMed ID: 9153985
    [No Abstract]   [Full Text] [Related]  

  • 10. Worldwide clinical experience with ACE inhibitors: the role of quinapril. Proceedings of investigators' meeting. Marbella, Spain, June 10-11, 1989.
    J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S1-63. PubMed ID: 1691401
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cardiovascular diseases. Improvement of the endothelial function as strategic therapeutic aim].
    Z Kardiol; 1998 Jun; 87(6 Suppl Besserung):1-4. PubMed ID: 9698652
    [No Abstract]   [Full Text] [Related]  

  • 12. Angiotensin-converting enzyme inhibition in patients with coronary artery disease and preserved left ventricular function Ischemia Management with Accupril post-bypass graft via inhibition of angiotensin-converting enzyme (IMAGINE) compared with the other major trials in coronary artery disease.
    van Gilst WH; Warnica JW; Baillot R; Johnstone D; Calciu CD; Block P; Myers MG; Chocron S; Rouleau JL;
    Am Heart J; 2006 Jun; 151(6):1240-6. PubMed ID: 16781228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ischemia Management with Accupril post bypass Graft via Inhibition of angiotensin coNverting enzyme (IMAGINE): a multicentre randomized trial - design and rationale.
    Warnica JW; Gilst WV; Baillot R; Johnstone D; Block P; Myers MG; Chocron S; Ave SD; Martineau P; Rouleau JL
    Can J Cardiol; 2002 Nov; 18(11):1191-200. PubMed ID: 12464983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quinapril demonstrates improved endothelium-mediated vasodilation in patients with chronic heart failure.
    Compr Ther; 1998 Jan; 24(1):38. PubMed ID: 9452901
    [No Abstract]   [Full Text] [Related]  

  • 15. Genotype-dependent increase in plasma ACE activity after CABG is prevented by ACE inhibition.
    van Geel PP; Buikema H; Rouleau JL; van Gilst WH
    Can J Cardiol; 2003 May; 19(6):701-4. PubMed ID: 12774785
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of ACE inhibitors on angiographic restenosis after coronary stenting (PARIS): double-blind randomized trial].
    Gnecchi M; Ardissino D
    Ital Heart J Suppl; 2001 Sep; 2(9):1027-8. PubMed ID: 11675825
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of angiotensin-converting enzyme inhibitors in the coronary artery bypass patient.
    Lazar HL
    Ann Thorac Surg; 2005 Mar; 79(3):1081-9. PubMed ID: 15734453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute effects of ACE inhibition on coronary endothelial dysfunction.
    Nickenig G; Stäblein A; Wassmann S; Wyen C; Müller C; Böhm M
    J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):361-4. PubMed ID: 11967824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating intercellular cell adhesion molecule-1, endothelin-1 and von Willebrand factor-markers of endothelial dysfunction in uncomplicated essential hypertension: the effect of treatment with ACE inhibitors.
    Hlubocká Z; Umnerová V; Heller S; Peleska J; Jindra A; Jáchymová M; Kvasnicka J; Horký K; Aschermann M
    J Hum Hypertens; 2002 Aug; 16(8):557-62. PubMed ID: 12149661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of smoking status on angiotensin-converting enzyme inhibition-related improvement in coronary endothelial function. TREND Investigators. Trial on Reversing Endothelial Dysfunction.
    Schlaifer JD; Mancini GB; O'Neill BJ; Pitt B; Haber HE; Pepine CJ
    Cardiovasc Drugs Ther; 1999 May; 13(3):201-9. PubMed ID: 10439882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.